The bacterial lysate Lantigen B reduces the number of acute episodes in patients with recurrent infections of the respiratory tract: The results of a double blind, placebo controlled, multicenter clinical trial

Studies in the 1970s and 1980s reported that bacterial lysates (BL) had a prophylactic effect on recurrent respiratory tract infections (RRTI). However, controlled clinical study procedures have evolved substantially since then. We performed a trial using updated methods to evaluate the efficacy of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Immunol Lett
Main Authors: Braido, Fulvio, Melioli, Giovanni, Candoli, Piero, Cavalot, Andrea, Di Gioacchino, Mario, Ferrero, Vittorio, Incorvaia, Cristoforo, Mereu, Carlo, Ridolo, Erminia, Rolla, Giovanni, Rossi, Oliviero, Savi, Eleonora, Tubino, Libero, Reggiardo, Giorgio, Baiardini, Ilaria, di Marco, Eddi, Rinaldi, Gilberto, Canonica, Giorgio Walter, Accorsi, Carlo, Bossilino, Claudia, Bonzano, Laura, DiLizia, Michela, Fedrighini, Barbara, Garelli, Valentina, Gerace, Vincenzo, Maniscalco, Sara, Massaro, Ilaria, Messi, Alessandro, Milanese, Manlio, Peveri, Silvia, Penno, Arminio, Pizzimenti, Stefano, Pozzo, Tiziana, Raie, Alberto, Regina, Sergio, Sclifò, Francesca
Formato: Artigo
Idioma:Inglês
Publicado em: The Authors. Published by Elsevier B.V. 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7173099/
https://ncbi.nlm.nih.gov/pubmed/25445613
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.imlet.2014.10.026
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados